Feb 24, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Feb 23, 2018 - Which big biotech stock wins in a head-to-head matchup?
Feb 23, 2018 - Sorrento has a diverse pipeline of developing therapeutics.Next-generation CAR-T based on CD38 has substantial value.Strong management from the leadership of Dr. Henry Ji to push for robust growth.
Feb 22, 2018 - Good News: Dividend income will be up 28.6% in 2018 with the new portfolio construction.Bad News: Portfolio value only up 9% excluding dividends, and 14.1% with them.Final dividend yield was 5.1% on o
Feb 22, 2018 - Merck (MRK) to buy Australian oncolytic immunotherapies maker Viralytics Limited to strengthen its presence in the fast growing immuno-oncology market.
Feb 21, 2018 - Heron is worth buying at dips.Aimmune’s lead product candidate succeeds in late-stage study.Voyager and AbbVie sign exclusive agreement.
Feb 20, 2018 - Sharp market correction triggered by interest rate concerns creates opportunities.Market transitions into a more typical rally and pullback mode, with a continued firm uptrend.Biotech stocks are exper
Feb 20, 2018 - Results from a Phase 3 clinical trial evaluating Celgene's (NASDAQ:CELG) OTEZLA (apremilast) in patients with active Behçet’s Disease with oral ulcers demonstrated a treatment effect. The
Feb 20, 2018 - Although Juno Therapeutics' (JUNO) product portfolio lacks revenue figures, the company's most advanced pipeline candidates, JCAR017 and JCAR014, might still drive the stock in Q4.
Feb 19, 2018 - David Rolfe Axes TreeHouse Foods, Exxon Mobil in 4th Quarter, Stocks: THS,XOM,CELG,T,PYPL,BRK.B,AAPL,GOOGL,V,FAST, David Rolfe, release date:Feb 19, 2018